WO2004073619A3 - Ccr8 antagonists - Google Patents
Ccr8 antagonists Download PDFInfo
- Publication number
- WO2004073619A3 WO2004073619A3 PCT/US2004/004256 US2004004256W WO2004073619A3 WO 2004073619 A3 WO2004073619 A3 WO 2004073619A3 US 2004004256 W US2004004256 W US 2004004256W WO 2004073619 A3 WO2004073619 A3 WO 2004073619A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ccr8
- ccr8 antagonists
- benzenesulfonamide
- antagonists
- nominated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
This invention relates to certain substituted benzenesulfonamide and their use for inhibiting the chemokine receptor nominated CCR8. The generic structure for these compounds, as defined herein is that of a benzenesulfonamide of formula (I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44756003P | 2003-02-14 | 2003-02-14 | |
US60/447,560 | 2003-02-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004073619A2 WO2004073619A2 (en) | 2004-09-02 |
WO2004073619A3 true WO2004073619A3 (en) | 2005-03-24 |
Family
ID=32908458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/004256 WO2004073619A2 (en) | 2003-02-14 | 2004-02-13 | Ccr8 antagonists |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2004073619A2 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20055498A0 (en) * | 2005-09-16 | 2005-09-16 | Biotie Therapies Corp | Sulfonamides |
GB0705400D0 (en) | 2007-03-21 | 2007-05-02 | Univ Aberdeen | Therapeutic compounds andm their use |
GB0817208D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | Therapeutic apsap compounds and their use |
GB0817207D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | therapeutic apsac compounds and their use |
AU2010223919B2 (en) | 2009-03-13 | 2016-03-31 | Les Laboratoires Servier | Methods and compositions for cell-proliferation-related disorders |
AU2010234526B2 (en) | 2009-04-06 | 2016-07-21 | Agios Pharmaceuticals, Inc. | Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use |
JP5764555B2 (en) | 2009-06-29 | 2015-08-19 | アジオス ファーマシューティカルズ, インコーポレイテッド | Therapeutic compositions and related methods of use |
UA107667C2 (en) | 2009-06-29 | 2015-02-10 | Аджиос Фармасьютікалз, Інк. | Medical compounds stimulating activity of pyruvate kinase m2, compositions on their basis and use in the treatment of cancer |
CA2793836C (en) | 2009-10-21 | 2020-03-24 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
WO2011050210A1 (en) | 2009-10-21 | 2011-04-28 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
ES2642109T3 (en) * | 2009-12-09 | 2017-11-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds for use in the treatment of cancer characterized by having an IDH mutation |
WO2012083246A1 (en) | 2010-12-17 | 2012-06-21 | Agios Pharmaceuticals, Inc. | Novel n- (4- (azetidine - 1 - carbonyl) phenyl) - (hetero - ) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators |
JP6092118B2 (en) | 2010-12-21 | 2017-03-08 | アジオス ファーマシューティカルズ, インコーポレイテッド | Bicyclic PKM2 activator |
TWI549947B (en) | 2010-12-29 | 2016-09-21 | 阿吉歐斯製藥公司 | Therapeutic compounds and compositions |
BR112013028422B8 (en) | 2011-05-03 | 2022-01-11 | Agios Pharmaceuticals Inc | Pyruvate kinase activators for use in therapy |
CN102827073A (en) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | Therapeutically active compositions and application methods thereof |
CN102827170A (en) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | Active treatment compositions and use method thereof |
KR101893112B1 (en) | 2012-01-06 | 2018-08-30 | 아지오스 파마슈티컬스 아이엔씨. | Therapeutically active compounds and their methods of use |
US9474779B2 (en) | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
WO2014062511A1 (en) | 2012-10-15 | 2014-04-24 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
GB201311361D0 (en) | 2013-06-26 | 2013-08-14 | Pimco 2664 Ltd | Compounds and their therapeutic use |
WO2015003360A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
WO2015006591A1 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | 2,4- or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer |
US9579324B2 (en) | 2013-07-11 | 2017-02-28 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
WO2015003355A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
US20150031627A1 (en) | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
AU2015229214B2 (en) | 2014-03-14 | 2019-07-11 | Les Laboratoires Servier | Pharmaceutical compositions of therapeutically active compounds |
HUE057569T2 (en) | 2014-12-17 | 2022-05-28 | Pimco 2664 Ltd | N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and n-(-4hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)-benzenesulfonamide compounds and their therapeutic use |
EP4344703A1 (en) | 2015-06-11 | 2024-04-03 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
SG11201803088PA (en) | 2015-10-15 | 2018-05-30 | Agios Pharmaceuticals Inc | Combination therapy for treating malignancies |
DK3362066T3 (en) | 2015-10-15 | 2021-11-22 | Les Laboratoires Servier Sas | COMBINATION THERAPY FOR THE TREATMENT OF MALIGNITIES |
US10980788B2 (en) | 2018-06-08 | 2021-04-20 | Agios Pharmaceuticals, Inc. | Therapy for treating malignancies |
JP2023540661A (en) * | 2020-07-03 | 2023-09-26 | ナンキン イムノファージ バイオテック カンパニー リミテッド | Methods and compositions for targeting Tregs using CCR8 inhibitors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6133442A (en) * | 1994-12-20 | 2000-10-17 | Hoffmann-La Roche Inc. | Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
-
2004
- 2004-02-13 WO PCT/US2004/004256 patent/WO2004073619A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6133442A (en) * | 1994-12-20 | 2000-10-17 | Hoffmann-La Roche Inc. | Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
Also Published As
Publication number | Publication date |
---|---|
WO2004073619A2 (en) | 2004-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004074438A3 (en) | Ccr8 antagonists | |
WO2004073619A3 (en) | Ccr8 antagonists | |
WO2003028641A3 (en) | Mch receptor antagonists | |
WO2006044504A8 (en) | Cgrp receptor antagonists | |
WO2002081430A3 (en) | Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors | |
WO2005113534A3 (en) | Cxcr1 and cxcr2 chemokine antagonists | |
WO2006047196A3 (en) | Cgrp receptor antagonists | |
WO2002060900A3 (en) | Antagonists of mcp-1 function and methods of use thereof | |
WO2006068826A3 (en) | 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors | |
WO2004082822A3 (en) | Methods for isolating crystalline form i of 5-azacytidine | |
WO2004035569A3 (en) | Novel compounds with antibacterial activity | |
WO2004092166A3 (en) | Cgrp receptor antagonists | |
WO2005000820A3 (en) | 4-cyanopyrazole-3-carboxamide derivatives preparation and application thereof as cb1 cannabinoid antagonists | |
IL185871A0 (en) | N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor | |
WO2005072308A3 (en) | Cgrp receptor antagonists | |
EP2078721A3 (en) | Thieno-pyrimidime compounds having fungicidal activity | |
WO2006099268A3 (en) | Cgrp receptor antagonists | |
WO2006004684A8 (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
WO2004091514A3 (en) | Cgrp receptor antagonists | |
WO2003024928A3 (en) | Novel aminoazetidine, -pyrrolidine and -piperidine derivatives | |
WO2006047415A3 (en) | FACTOR Xa COMPOUNDS | |
GEP20104880B (en) | Carboxamide derivatives as muscarinic receptor antagonists | |
WO2007072201A3 (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
WO2006044449A3 (en) | Cgrp receptor antagonists | |
WO2007014008A3 (en) | Benzenesulfonamide inhibitor of ccr2 chemokine receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
122 | Ep: pct application non-entry in european phase |